TheraRadar
← Back
Data updated: Mar 29, 2026

GRAVITI PHARMS

Infectious DiseaseCardiovascularGastroenterology
Generics

GRAVITI PHARMS is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology.

2002
Since
15
Drugs
-
Trials
419
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
AMLODIPINE BESYLATE 2026-02-17
Manufacturing (CMC)
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-13
Labeling
TRAMADOL HYDROCHLORIDE 2026-02-12
Manufacturing (CMC)
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
AMLODIPINE BESYLATE 2026-01-26
Manufacturing (CMC)
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 33%
1 drugs
Cardiovascular 33%
1 drugs
Gastroenterology 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Pfizer big-pharma
Infectious Disease, Gastroenterology
WAYLIS THERAP big-pharma
Cardiovascular, Infectious Disease, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular
WARNER CHILCOTT LLC specialty
Cardiovascular, Gastroenterology, Infectious Disease